您的位置: 首页 > 农业专利 > 详情页

TREATMENT OF CANCER USING ANTIGENIC CHIMERIC RECEPTOR IN COMBINATION WITH A MOLECULE INHIBITOR PROMOTING THE M2 PHENOTYPE OF MACROPHAG
专利权人:
НОВАРТИС АГ (CH);ДЗЕ ТРАСТИЗ ОФ ДЗЕ ЮНИВЕРСИТИ ОФ ПЕНСИЛЬВАНИЯ (US)
发明人:
ДЖИЛЛ, Саар (US),РУЕЛЛА, Марко (US),КЛИЧИНСКИ, Майкл (US)
申请号:
RU2019105693
公开号:
RU2019105693A
申请日:
2017.08.01
申请国别(地区):
RU
年份:
2020
代理人:
摘要:
The invention provides compositions and methods for treating diseases associated with expression of an antigen, e.g., a solid tumor antigen or antigen expressed on a tumor associated with TAMs and/or MDSCs, by administering a recombinant T cell comprising a CAR binding to said antigen, as described herein, in combination with an inhibitor of a pro-M2 macrophage molecule, e.g., described herein. The invention also provides kits and compositions described herein.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充